🇺🇸 FDA
Pipeline program

melphalan hydrochloride for injection

2021PHD013-001

Approved small_molecule active

Quick answer

melphalan hydrochloride for injection for Multiple Myeloma is a Approved program (small_molecule) at CASI Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
CASI Pharmaceuticals
Indication
Multiple Myeloma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials